Team: Bios

Vaughn M. Kailian Managing Director

Vaughn Kailian joined MPM's Boston office in 2005 and brought to MPM unparalleled success in the stewardship of commercial biotech and pharmaceutical companies. From 2002 - 2004, he served as vice chair of the Board of Directors of Millennium Pharmaceuticals, Inc.; and was head of the Millennium commercial organization. From 1990 - 2002, Mr. Kailian served as CEO, president and director of COR Therapeutics, Inc. He became the CEO of COR shortly after the company was founded, took the company public in 1991, raised almost $1 billion in public market capital, and led the $2 billion merger with Millennium in 2002. Earlier in his career, Mr. Kailian held various international and U.S. general management, marketing and sales positions at Marion Merrell Dow, Inc. and its predecessor companies including president and general manager, Merrell Dow USA; and corporate vice president of Global Commercial Development, Marion Merrell Dow, Inc. He earned his B.A. degree at Tufts University. Mr. Kailian is also a member of the board of BIO Ventures for Global Health and the New England Healthcare Institute.

Present Boards
Cephalon, Inc. (NASDAQ:CEPH)
Chairman, Cerimon Pharmaceuticals, Inc.
Chairman, Elixir Pharmaceuticals, Inc.
NicOx, S.A. (Euronet Paris:COX)
Executive Chairman, Valeritas
Xanodyne Pharmaceuticals, Inc.

Past Boards
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)
Axys Pharmaceuticals, Inc. (NASDAQ:AXPH)
COR Therapeutics, Inc. (NASDAQ:CORR)
Ikaria Holdings, Inc.
Memory Pharmaceuticals (NASDAQ:MEMY)
Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM)
ViaCell, Inc. (NASDAQ:VIAC)